K.-A. Kreuzer
- Hematology top 5%
- Acute Myeloid Leukemia Research 2
- Chronic Myeloid Leukemia Treatments 1
- Iron Metabolism and Disorders 1
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 2
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Hemoglobinopathies and Related Disorders 1
-
- Wnt/β-catenin signaling in development and cancer 1
-
- Lymphoma Diagnosis and Treatment 1
- Co-authors
- Christiane EderTamara AlpermannAnnette FasanVera GrossmannSusanne SchnittgerNorbert SchmitzWolfgang KernTorsten Haferlach
- Cited by
- HematologyGeneticsCancer Research
- Journals
- Leukemia (2 papers)Current Cancer Drug Targets (1 paper)TumorDiagnostik & Therapie (1 paper)
- Partner nations
- GermanyUnited Kingdom
In The Last Decade
K.-A. Kreuzer
3 papers receiving 207 citations
Peers
Comparison fields: 5 of 25
- Hematology 162
- Genetics 103
- Cancer Research 38
- Rheumatology 27
- Molecular Biology 90
Countries citing papers authored by K.-A. Kreuzer
This map shows the geographic impact of K.-A. Kreuzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.-A. Kreuzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.-A. Kreuzer more than expected).
Fields of papers citing papers by K.-A. Kreuzer
This network shows the impact of papers produced by K.-A. Kreuzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.-A. Kreuzer. The network helps show where K.-A. Kreuzer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside K.-A. Kreuzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 32 | |
| 2 | BENDAMUSTINE (B), followed by OBINUTUZUMAB (G, GA101) and VENETOCLAX (A, ABT-199) in patients with chronic lymphocytic leukemia (CLL): CLL2-BAG PHASE-II-TRIAL of the German CLL Study Group (GCLLSG) | 2017 | 0 |
| 3 | 2012 | 153 | |
| 4 | 2012 | 0 | |
| 5 | 2010 | 25 |
About K.-A. Kreuzer
K.-A. Kreuzer is a scholar working on Genetics, Hematology and Immunology, having authored 5 papers that have together received 210 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Hemoglobinopathies and Related Disorders (1 paper), Wnt/β-catenin signaling in development and cancer (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Chronic Myeloid Leukemia Treatments (1 paper) and Iron Metabolism and Disorders (1 paper). The work is most often cited by research in Hematology (162 citations), Genetics (103 citations) and Cancer Research (38 citations). K.-A. Kreuzer has collaborated with scholars based in Germany and United Kingdom. Frequent co-authors include Christiane Eder, Tamara Alpermann, Annette Fasan, Vera Grossmann, Susanne Schnittger, Norbert Schmitz, Wolfgang Kern, Torsten Haferlach, Christoph Schmid and Claudia Haferlach. Their work appears in journals such as Leukemia, Current Cancer Drug Targets and TumorDiagnostik & Therapie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.